www.interpharma.co.th IP_OCS/011/2020 8th June 2020 Subject: Notify the Resolutions of the Board of Directors Meeting, Change of Objectives of Funds Usage, Acquisition of Assets, The Issuance of Debentures and Fix the

three years or upon occurrence of a widespread adverse incident;   (2) To adjust the submission schedule for the Risk Level Assessment (RLA) report and IT audit report to be within the same period (during

a fair price from the date of the change, the proportion of investment. By recognized profit on changes in the proportion of investment in the period of 9 months in year 2017 amount 6.84 million baht

The Securities and Exchange Commission (SEC) held a meeting with the Department of Climate Change and Environment (DCCE), the Ministry of Natural Resources and Environment (MNRE), the Thailand

PUBLIC COMPANY LIMITED Disclosure Business News ( 4 record(s) found) Date Time Heading Link 17/08/2020 18:07 Notification of the Resolutions of the Board of Directors Approving Change of Interim Dividend

adjust the assumptions for cash flows projections of those subsidiaries to calculate the recoverable amount appropriately, and to consider the adequacy and appropriateness of the impairment loss for

. During the temporarily suspension, the Company need to adjust compensation scheme to the employees to enable the Company to surpass the challenge of cash sufficiency during the crisis and be complied with

, the changes are as follows: - 1) total assets as of 31 December 2018 before retrospectively adjust was THB 14,329.7mn and after the retrospectively adjust was THB 14,376.4mn, an increase of THB 46.7mn

are illustrated as below: 1) total assets as of 31 December 2018 before retrospectively adjust was THB 14,329.7mn and after the retrospectively adjust was THB 14,376.4mn, an increase of THB 46.7mn. 2

take-home products. Executive Summary 2 Overall Operating Results of the Company in Q3/2020 Q3/19 Q3/20 9M/19 9M/20 Change +/(-) (THB million) YoY 9M Operating Revenue 312 198 (37%) 911 561 (38%) Gross